A. Rider
Impact in
- Oncology top 10%
- Cancer survivorship and care
- Bone health and treatments
- Cancer Diagnosis and Treatment
-
- Lung Cancer Treatments and Mutations
- Prostate Cancer Treatment and Research
Papers in ⓘ
- Oncology 41
- Bone health and treatments 12
- Cancer Diagnosis and Treatment 8
- Cancer survivorship and care 7
- Cancer Treatment and Pharmacology 6
-
- Advanced Breast Cancer Therapies 18
- Co-authors
- Gavin Taylor‐Stokes (2 shared papers)Adam Roughley (4 shared papers)Shrividya Iyer (1 shared paper)David Geltner (1 shared paper)Zev Sthoeger (1 shared paper)Zvi Bentwich (1 shared paper)Roger von Moos (8 shared papers)Guy Hechmati (8 shared papers)
- Journals
- Annals of Oncology (16 papers)Value in Health (11 papers)Journal of Clinical Oncology (7 papers)Future Oncology (5 papers)Cancer Research (4 papers)
- Partner nations
- United KingdomUnited StatesSwitzerland
In The Last Decade
A. Rider
66 papers receiving 510 citations
Peers
Comparison fields: 5 of 69
- Oncology 308
- Pulmonary and Respiratory Medicine 184
- Otorhinolaryngology 23
- Hematology 45
- Rheumatology 49
Countries citing papers authored by A. Rider
This map shows the geographic impact of A. Rider's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Rider with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Rider more than expected).
Fields of papers citing papers by A. Rider
This network shows the impact of papers produced by A. Rider. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Rider. The network helps show where A. Rider may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Rider, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 165 | |
| 2 | Systemic lupus erythematosus in 49 Israeli males: a retrospective study. | 1988 | 48 |
| 3 | 2013 | 29 | |
| 4 | 2018 | 27 | |
| 5 | 2017 | 26 | |
| 6 | 2014 | 22 | |
| 7 | 2021 | 17 | |
| 8 | 2022 | 16 | |
| 9 | 2019 | 14 | |
| 10 | 2020 | 13 | |
| 11 | 2021 | 12 | |
| 12 | 2019 | 12 | |
| 13 | 2019 | 9 | |
| 14 | 2019 | 9 | |
| 15 | 2021 | 8 | |
| 16 | 2022 | 7 | |
| 17 | 2018 | 7 | |
| 18 | 2021 | 5 | |
| 19 | 2021 | 5 | |
| 20 | 2017 | 4 |
About A. Rider
A. Rider is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Genetics, Cancer Research and Hematology, having authored 71 papers that have together received 521 indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (19 papers), Advanced Breast Cancer Therapies (18 papers), Bone health and treatments (12 papers), Breast Cancer Treatment Studies (8 papers), Cancer Diagnosis and Treatment (8 papers), Cancer survivorship and care (7 papers), Cancer Treatment and Pharmacology (6 papers) and Economic and Financial Impacts of Cancer (6 papers). The work is most often cited by research in Oncology (308 citations), Pulmonary and Respiratory Medicine (184 citations), Otorhinolaryngology (23 citations), Hematology (45 citations) and Rheumatology (49 citations). A. Rider has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include Gavin Taylor‐Stokes, Adam Roughley, Shrividya Iyer, David Geltner, Zev Sthoeger, Zvi Bentwich, Roger von Moos, Guy Hechmati, Katie Lewis and Jean‐Jacques Body. Their work appears in journals such as Annals of Oncology, Value in Health, Journal of Clinical Oncology, Future Oncology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.